Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1COVID-19 1

Interventions

Surveys and Questionnaires 7COVID-19 Vaccines 4Surgical Procedures, Operative 3Specimen Handling 3Blood Specimen Collection 3Pandemic Preparedness 2Data Collection 2BNT162 Vaccine 22019-nCoV Vaccine mRNA-1273 2sinovac COVID-19 vaccine 1regorafenib 1heterologous prime boost COVID-19 vaccination 1Telemedicine 1Sorafenib 1Serologic Tests 1Patient Reported Outcome Measures 1Meopa 1Mastectomy, Segmental 1High-Throughput Nucleotide Sequencing 1Drug Therapy 1Colonoscopy 1Ad26COVS1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × COVID-19 × Ad26COVS1 × Clear all
NCT04930055 2023-05-19

Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

Indiana University

Terminated
2,206 enrolled

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡